在癌症免疫治疗中向巨细胞:边界和挑战
Yu'e Liu1, Huabing Tan2, Jingyuan Dai3
1Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China; Department of Pediatric Hematology-Oncology, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Journal of advanced research
|January 8, 2025
概括
本综述探讨了针对巨细胞的尖端癌症疗法,包括改变巨细胞的可塑性和使用嵌合抗原受体 (CAR) -巨细胞,以提高免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 癌症免疫疗法,包括基于T细胞的策略,面临着挑战.
- 巨细胞是关键的免疫细胞,连接先天性和适应性免疫.
- 向巨细胞为癌症治疗提供了一个有希望的治疗途径.
研究的目的:
- 提出对巨细胞向癌症治疗的先进见解和未来方向.
- 引导开发新且有效的癌症治疗方法.
- 审查目前操纵癌症巨细胞的策略.
主要方法:
- 分析调节巨细胞可塑性的策略 (M2到M1表型).
- 复习仿真抗原受体 (CAR) -巨细胞的设计,发展和益处.
- 检查针对巨细胞菌检查点的挑战和解决方案.
主要成果:
- 巨细胞的可塑性为癌症治疗提供了一个独特的治疗点.
- 汽车巨体代表了一个新兴和有前途的基于细胞的疗法.
- 针对细胞检查点提出了挑战,但具有潜力.
结论:
- 向巨细胞的疗法,包括塑性调节和CAR巨细胞,正在推进癌症治疗.
- 克服细胞检查点向的挑战,可以进一步增强免疫疗法.
- 这些策略旨在提高癌症免疫治疗的疗效.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Immune Surveillance by NK Cells and Phagocytes
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...


